Cytochrome P450 polymorphisms: Risk factors for lung cancer?

被引：0
|
作者：
Benhamou, S [1 ]
Bonaiti-Pellie, C [1 ]
机构：
[1] Inst Gustave Roussy, Canc Epidemiol Unit, INSERM U351, F-94805 Villejuif, France
来源：
CLINICAL AND BIOLOGICAL BASIS OF LUNG CANCER PREVENTION | 1998年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：207 / 212
页数：6
相关论文
共 50 条
  • [21] Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
    F Peter Guengerich
    Martha V Martin
    Christal D Sohl
    Qian Cheng
    Nature Protocols, 2009, 4 : 1245 - 1251
  • [22] Isoform-Dependent Effects of Cytochrome P450 Oxidoreductase Polymorphisms on Drug Metabolism by Cytochrome P450 Enzymes in Dogs
    Martinez, Stephanie E.
    Pandey, Amit V.
    Court, Michael H.
    FASEB JOURNAL, 2019, 33
  • [23] Differences of cytochrome P450 1B1 polymorphisms on prostate cancer risk between races
    Kato, Taku
    Hashimoto, Yutaka
    Wong, Ryan
    Mitsui, Yozo
    Maekawa, Shigekatsu
    Yamamura, Soichiro
    Majid, Shahana
    Saini, Sharanjot
    Shahryari, Varahram
    Tabatabai, Laura
    Shiina, Hiroaki
    Dahiya, Rajvir
    Deguchi, Takashi
    Tanaka, Yuichiro
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Cytochrome P450 2E1 genetic polymorphisms and the risk of gastric cancer in a Chinese population
    Lin, C
    Yu, SZ
    Zhang, ZF
    EPIDEMIOLOGY, 2000, 11 (04) : S82 - S82
  • [25] Cytochrome P450 1A1 Gene Polymorphisms and Endometrial Cancer Risk A Meta-Analysis
    Sergentanis, Theodoros N.
    Economopoulos, Konstantinos P.
    Choussein, Souzana
    Vlahos, Nikos F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (02) : 323 - 331
  • [26] Cytochrome P450
    P. H. Roos
    N. Jakubowski
    Analytical and Bioanalytical Chemistry, 2008, 392 : 1015 - 1017
  • [27] Cytochrome P450
    Roos, P. H.
    Jakubowski, N.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 392 (06) : 1015 - 1017
  • [28] Cytochrome P450 3A polymorphisms and immunosuppressive drugs
    Thervet, E
    Legendre, C
    Beaune, P
    Anglicheau, D
    PHARMACOGENOMICS, 2005, 6 (01) : 37 - 47
  • [29] Polymorphisms of cytochrome p450 and adverse events of tamoxifen therapy
    Ignatova, A.
    Zacharenkova, J.
    Dudina, I.
    Savelyeva, M.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S20 - S21
  • [30] Characterisation of cytochrome p450 polymorphisms using the Invader system®.
    Neville, M
    Walton, R
    Aizenstein, B
    Maguire, M
    Seltzer, R
    Hogan, K
    Neri, B
    de Arruda, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 469 - 469
12345